Warfant 5 mg Tablets
*Company:
ADVANZ PharmaStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 14 June 2022
File name
WARFANT_Warfarin sodium clathrate Tablet 5 mg_SPC_IE.pdf
Reasons for updating
- Other
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Type IB, category C.I.z.variation application to update SmPC and corresponding sections of PIL in line with PRAC recommendation on signals.
Updated on 14 June 2022
File name
WARFANT_Warfarin sodium clathrate Tablet 1, 3, 5mg_PIL_IE.pdf
Reasons for updating
- Change to other sources of information section
Free text change information supplied by the pharmaceutical company
Type IB, category C.I.z.variation application to update SmPC and corresponding sections of PIL in line with PRAC recommendation on signals.
Updated on 31 December 2021
File name
Warfant 5mg Tablets_SPC_IE.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 31 December 2021
File name
Warfant Tablets_PIL_IE.pdf
Reasons for updating
- New PIL for new product
ADVANZ Pharma
Address:
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United KingdomMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230